iRadimed Corporation (NASDAQ:IRMD) to Issue Quarterly Dividend of $0.20

Posted by Donna Armstrong on Feb 10th, 2026

iRadimed Corporation (NASDAQ:IRMD – Get Free Report) declared a quarterly dividend on Tuesday, February 10th. Shareholders of record on Monday, February 23rd will be given a dividend of 0.20 per share by the medical equipment provider on Friday, March 6th. This represents a c) dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Monday, February 23rd. This is a 17.6% increase from iRadimed’s previous quarterly dividend of $0.17.

iRadimed has a payout ratio of 34.2% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect iRadimed to earn $2.00 per share next year, which means the company should continue to be able to cover its $0.68 annual dividend with an expected future payout ratio of 34.0%.

iRadimed Stock Up 9.3%

Shares of IRMD stock traded up $8.88 during mid-day trading on Tuesday, reaching $104.85. 114,367 shares of the company’s stock traded hands, compared to its average volume of 77,833. The company’s 50-day moving average price is $97.82 and its 200-day moving average price is $83.09. The company has a market cap of $1.33 billion, a P/E ratio of 63.55 and a beta of 1.11. iRadimed has a 12 month low of $47.48 and a 12 month high of $107.90.

iRadimed (NASDAQ:IRMD – Get Free Report) last posted its quarterly earnings data on Tuesday, February 10th. The medical equipment provider reported $0.54 earnings per share for the quarter, beating analysts’ consensus estimates of $0.49 by $0.05. iRadimed had a return on equity of 22.93% and a net margin of 26.31%.The company had revenue of $22.69 million during the quarter, compared to analyst estimates of $21.60 million. iRadimed has set its Q1 2026 guidance at 0.440-0.480 EPS and its FY 2026 guidance at 2.060-2.210 EPS. Equities analysts predict that iRadimed will post 1.66 earnings per share for the current year.

About iRadimed

(Get Free Report)

iRadimed Corporation designs, develops and manufactures medical device solutions for MRI environments. The company’s core product line consists of MRI-compatible infusion systems engineered to deliver precise fluid management during magnetic resonance imaging procedures. These devices are crafted to minimize electrical noise and interference, ensuring both patient safety and image clarity in diagnostic and interventional settings.

In addition to infusion pumps, iRadimed offers a range of complementary accessories and monitoring solutions tailored to MRI suites.